Why is Injective up today? INJ rose 27.4% to $9.16 after announcing US regulatory meetings, as trading volume and leveraged positions grew.
Author: Kritika Gupta
Injective (INJ), a Layer-1 blockchain for decentralized finance, on-chain order books, perpetuals, and real-world asset tokenization with native cross-chain interoperability, rose 27.4% over the past 24 hours to $9.16 USD, according to CoinGecko’s October 16 snapshot. The rally followed Injective’s announcement that its leadership met White House, SEC, and CFTC officials to discuss tokenization and on-chain finance within the US regulatory framework.
This article is for informational purposes only and does not constitute financial advice.
Injective’s October 15 announcement supplied the clearest project-specific catalyst. The official @injective account said CEO Eric Chen and the project’s legal, policy, and research leaders met White House, SEC, and CFTC officials in Washington on October 14, 2026. The discussions covered tokenization and on-chain finance; the announcement did not establish regulatory approval or a policy change.
Injective’s post also highlighted SEC-registered transfer agent status, CFTC-regulated INJ futures, and Injective Mint. These developments reinforced the institutional narrative around its tokenization infrastructure.
Separately, Injective announced Gulf Labs as an institutional validator around October 8 and published a revised whitepaper emphasizing native RWA tokenization and iAssets. CoinGlass data showed rising derivatives participation and short liquidations alongside the rally, although the supplied research provides no exact liquidation total. These factors accompanied the move without proving a single cause.
CoinGecko recorded $328.24 million in 24-hour volume, up 147.2%, versus recent daily readings of $50 million–$175 million. CoinGlass placed open interest at $224.34 million–$229.14 million; a Hyperliquid-specific report recorded growth, rather than a market-wide percentage.
Funding reached approximately +0.0100% per eight hours on major venues, with longs paying shorts. Lookonchain and TradingBeats tracked a Hyperliquid wallet holding approximately 246,900 INJ in leveraged longs worth $2.28 million. DefiLlama recorded TVL of $15.47 million–$15.53 million, up 17.02%–17.43% over 24 hours, indicating a measurable increase alongside trading activity.
Whale Factor (@WhaleFactor, 249,703 followers) described the daily chart as a structural breakout from a multi-year downtrend. That interpretation represents the analyst’s view, rather than a confirmed future price outcome.
Injective (@injective, 536,649 followers) emphasized its Washington meetings and revenue-funded Community BuyBack mechanism. No additional verified commentary from qualifying accounts appeared in the supplied research.
For caution, CoinGlass-related funding data provides a positioning signal rather than an opinion: positive funding shows longs paying shorts. Combined with Investing.com’s overbought RSI reading, it highlights leverage and momentum risks after the advance.
CoinGecko’s October 16, 2026 high supplies the immediate historical resistance reference at $9.33, with Investing.com’s analysis placing the area near $9.35. The October 15 lows establish the lower support reference at $7.07–$7.25.
The next major historical level supplied by the research is $52.62, based on March 14, 2024 price action. The research identifies no intervening major historical level. Investing.com’s 14-day RSI of 75.873 signals overbought conditions.
This article is for informational purposes only and does not constitute financial advice.
This is not financial advice. Always do your own research before making investment decisions.
Injective governance lists the IIP-709 vote on predictable exchange-message gas fees as closing around October 17, while Community BuyBack operations and Open Liquidity Program epochs continue through October. The research identifies no major upcoming cliff unlocks following vesting completion around January 2024, while ETF applications remain under review without confirmed approval dates.
Tokenization developments remain relevant, but approximately $225 million in open interest and comparatively limited TVL increase post-rally correction risk.
Injective’s 27.4% advance followed its announcement of meetings with White House, SEC, and CFTC officials on October 14, 2026. CoinGecko recorded a $9.16 price and $328.24 million in daily volume, while derivatives activity also accompanied the rally.
INJ’s catalysts include the IIP-709 governance vote, ongoing buybacks, institutional validator participation, and ETF reviews. Risks include a 14-day RSI of 75.873, leveraged positioning, and limited on-chain liquidity relative to market capitalization.
This article is for informational purposes only and does not constitute financial advice.
INJ’s historical references include $9.33–$9.35 from October 16, 2026, and $7.07–$7.25 from October 15, 2026. The research also identifies the March 14, 2024 all-time high of $52.62 as a historical reference, without establishing a price forecast.
Our Crypto Talk is committed to unbiased, transparent, and true reporting to the best of our knowledge. This news article aims to provide accurate information in a timely manner. However, we advise the readers to verify facts independently and consult a professional before making any decisions based on the content since our sources could be wrong too. Check our Terms and conditions for more info.
